22 May 2013
Keywords: dxs, help, search, blood, dna, cancer, markers
Article | 14 August 2006
UK-based pharmacogenomics firm DxS has been selected to take part in a three-year project aiming to identify circulating DNA tumor ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 August 2006
7 August 2006
21 May 2013
© 2013 thepharmaletter.com